Ajanta Pharma Promoter Ravi Agrawal Releases 6,910 Pledged Shares

Ravi Agrawal, a promoter of Ajanta Pharma Limited and trustee of Ravi Agrawal Trust, has reported the release of a pledge on 6,910 equity shares. The disclosure, made under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, indicates the shares were released due to 'Excess Pledge'. The event occurred on August 14, 2026, with the reporting date being August 19, 2026. The shares were originally pledged for business financing with Gabs Investments Pvt Ltd, with Aditya Birla Capital Limited as the lender and Barclays Securities (India) Private Limited as the DP. This action slightly reduces the promoter's encumbered shareholding.